As of June 3, 2025, Abcam PLC (ABC.L) reports a Forward P/E of 4083.72.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Abcam PLC's Forward P/E to Peers
To better understand Abcam PLC's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Abcam PLC (ABC.L) | 4083.72 |
| Probi AB (PROB.ST) | 243.07 |
| Arcticzymes Technologies ASA (AZT.OL) | 89.32 |
| Biofrontera AG (B8F.DE) | 72.66 |
| Bonesupport Holding AB (BONEX.ST) | 62.79 |
| Pharming Group NV (PHARM.AS) | 53.43 |
Compared to its competitors, Abcam PLC's Forward P/E is higher than all peers, reflecting higher growth expectations from investors.